SCHEMBL28631820

SCHEMBL28631820

CCOC(=O)C(=C=O)Cc1ccc2ccccc2n1

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.51
▸ CYSLTR1 Q9Y271 4/20 0.47
▸ CYSLTR2 Q9NS75 3/20 0.47
▸ KMT2A Q03164 4/20 0.46
▸ MEN1 O00255 3/20 0.46
▸ PRNP P04156 1/20 0.46
▸ MAPT P10636 2/20 0.45
▸ NPC1 O15118 2/20 0.45
▸ RAB9A P51151 2/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ ALOX5 P09917 1/20 0.44
▸ GPBAR1 Q8TDU6 2/20 0.43
▸ KDM4E B2RXH2 1/20 0.42
▸ GAA P10253 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ PTGDR2 Q9Y5Y4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28635314 0.83 CYP1A2 (0.55) CYP1A2CYSLTR1CYSLTR2KMT2AMEN1
SCHEMBL4728631 0.80 CYSLTR2 (0.60) CYP1A2CYSLTR1CYSLTR2KMT2AMEN1
SCHEMBL28634857 0.80 MEN1 (0.46) CYP1A2KMT2AMEN1MAPTNPC1
SCHEMBL11678915 0.79 CYP1A2 (0.51) CYP1A2CYSLTR1CYSLTR2KMT2AMEN1
SCHEMBL28547028 0.75 MEN1 (0.49) KMT2AMEN1MAPTSMN1; SMN2ALDH1A1
SCHEMBL140815 0.73 CYP1A2 (0.65) CYP1A2CYSLTR1CYSLTR2KMT2AMEN1
Acetic Acid SCHEMBL27459479 0.72 CYP1A2 (0.64) CYP1A2CYSLTR1CYSLTR2KMT2AMEN1
SCHEMBL17372711 0.72 CYP1A2 (0.64) CYP1A2CYSLTR1CYSLTR2KMT2AMEN1
SCHEMBL4623799 0.72 CYP1A2 (0.68) CYP1A2CYSLTR1CYSLTR2KMT2AMEN1
SCHEMBL31442421 0.72 MGAM (0.53) KMT2AMEN1PRNPMAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109761986-B Tricyclic derivative inhibitor, preparation method and application thereof 上海翰森生物医药科技有限公司 2021-10-08 — — CN disclosed
Send feedback